Health Care & Life Sciences » Pharmaceuticals | Endo International PLC

Endo International PLC | Balance Sheet

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,297
940
858
799
1,307
1,454
Total Accounts Receivable
726
1,287
1,731
1,040
529
510
Inventories
374
472
745
556
391
322
Other Current Assets
458
608
142
160
43
56
Total Current Assets
2,855
3,307
3,475
2,555
2,271
2,343
Net Property, Plant & Equipment
372
429
671
670
524
499
Total Investments and Advances
3
33
19
11
1
1
Intangible Assets
3,246
6,957
15,112
10,589
8,768
7,222
Other Assets
97
178
64
442
60
67
Total Assets
6,572
10,910
19,350
14,275
11,636
10,132
ST Debt & Current Portion LT Debt
415
156
329
131
34
Accounts Payable
260
308
344
127
85
Income Tax Payable
-
3
9
9
2
Other Current Liabilities
1,019
2,635
2,793
2,368
2,099
Total Current Liabilities
1,697
3,099
3,474
2,635
2,221
Long-Term Debt
3,324
4,202
8,252
8,141
8,242
Provision for Risks & Charges
1
-
-
-
-
Deferred Taxes
311
719
862
184
32
Other Liabilities
654
476
785
605
645
Total Liabilities
5,987
8,501
13,382
11,574
11,151
Common Equity (Total)
526
2,375
5,968
2,702
485
Total Shareholders' Equity
526
2,375
5,968
2,702
485
Total Equity
585
2,408
5,968
2,702
485
Liabilities & Shareholders' Equity
6,572
10,910
19,350
14,275
11,636
Accumulated Minority Interest
59
33
-
-
-

About Endo International

View Profile
Address
Minerva House
Dublin Dublin 4
Ireland
Employees -
Website http://www.endo.com
Updated 07/08/2019
Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The company operates through the following segments: U.